Kathleen P. Gallagher
Chief Program Officer; Director, Chief Executive Officer and President · 3 filings · Latest: Sep 18, 2026
Atrium Therapeutics, Inc.
Avidity Biosciences, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
RNA | KATHLEEN GALLAGHER | — | Jun 17, 2025 | Proposed Sale | $29.80 | 911 | $27.1K | — | |
RNA | KATHLEEN GALLAGHER | — | Jun 2, 2025 | Proposed Sale | $30.98 | 5,875 | $182.0K | — | |
RNA | KATHLEEN GALLAGHER | — | May 1, 2025 | Proposed Sale | $32.65 | 5,875 | $191.8K | — | |
RNA | KATHLEEN GALLAGHER | — | Feb 3, 2025 | Proposed Sale | $32.93 | 17,625 | $580.4K | — | |
RNA | KATHLEEN GALLAGHER | — | Jan 22, 2025 | Proposed Sale | $30.84 | 6,924 | $213.5K | — |